Literature DB >> 11702135

Postoperative fluid-attenuated inversion recovery MR imaging of cerebral gliomas: initial results.

M Essig1, R Metzner, M Bonsanto, H Hawighorst, J Debus, V Tronnier, M V Knopp, G van Kaick.   

Abstract

Fluid-attenuated inversion-recovery (FLAIR) imaging has shown to be a valuable imaging modality in the assessment of intra-axial brain tumors; however, no data are available about the role of this technique in the clinically important postoperative stage. The purpose of this study was to evaluate the diagnostic potential of FLAIR MR imaging in residual tumor after surgical resection of cerebral gliomas. Fifteen patients with residual cerebral gliomas were examined within the first 18 days after partial surgical resection of cerebral gliomas. The imaging protocol included T1-weighted spin echo, T2- and proton-density-weighted fast spin echo, and FLAIR imaging with identical slice parameters. T1 and FLAIR were repeated after contrast media application. Detection and delineation of residual tumor were the primary parameters of the image analysis. Additionally, the influence of image artifacts on the image interpretation was assessed. On FLAIR images residual signal abnormalities at the border of the resection cavities were observed in all patients, whereas T2- and T1-weighted images present residual abnormalities in 13 of 15 and 10 of 15 patients, respectively. The FLAIR imaging was found to be superior to conventional imaging sequences in the delineation of these changes and comparable to contrast enhanced T1-weighted imaging in the delineation of residual enhancing lesions. Because of protein cell components and blood byproducts within the resection cavity, FLAIR imaging was unable to suppress the cerebrospinal fluid (CSF) in 4 patients. After the decomposition of proteins and blood, CSF could again be completely suppressed and residual or recurrent tumors were clearly identified. Our preliminary study has shown that FLAIR may be a valuable diagnostic modality in the early postoperative MR imaging after resection of cerebral gliomas due to its better delineation of residual pathologic signal at the border of the resection cavity. It should therefore be integrated into the early and/or intraoperative MR imaging protocol.

Entities:  

Mesh:

Year:  2001        PMID: 11702135     DOI: 10.1007/s003300100856

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  10 in total

1.  Post-contrast FLAIR MR imaging of the brain in children: normal and abnormal intracranial enhancement.

Authors:  Hyun Woo Goo; Choong-Gon Choi
Journal:  Pediatr Radiol       Date:  2003-10-10

2.  Early imaging marker of progressing glioblastoma: a window of opportunity.

Authors:  Na Tosha N Gatson; Shane P Bross; Yazmin Odia; Gino J Mongelluzzo; Yirui Hu; Laura Lockard; Jesse J Manikowski; Anand Mahadevan; Syed A J Kazmi; Michel Lacroix; Andrew R Conger; Joseph Vadakara; Lakshmi Nayak; T Linda Chi; Minesh P Mehta; Vinay K Puduvalli
Journal:  J Neurooncol       Date:  2020-06-29       Impact factor: 4.130

3.  Positron emission tomography for the early postsurgical evaluation of pediatric brain tumors.

Authors:  Benoit Pirotte; Marc Levivier; Daniele Morelli; Patrick Van Bogaert; Dominique Detemmerman; Philippe David; Daniele Baleriaux; Jacques Brotchi; Serge Goldman
Journal:  Childs Nerv Syst       Date:  2004-12-10       Impact factor: 1.475

4.  Differential diagnosis by unenhanced FLAIR T2-weighted magnetic resonance images between solitary high grade gliomas and cerebral metastases appearing as contrast-enhancing cortico-subcortical lesions.

Authors:  Carmine Franco Muccio; Annachiara Tarantino; Gennaro Esposito; Alfonso Cerase
Journal:  J Neurooncol       Date:  2010-11-11       Impact factor: 4.130

5.  Semi-quantification of methionine uptake and flair signal for the evaluation of chemotherapy in low-grade oligodendroglioma.

Authors:  Bich-Ngoc-Thanh Tang; Niloufar Sadeghi; Fabrice Branle; Olivier De Witte; David Wikler; Serge Goldman
Journal:  J Neurooncol       Date:  2005-01       Impact factor: 4.130

6.  Contrast-enhanced FLAIR in the early diagnosis of infectious meningitis.

Authors:  Alesssandra Splendiani; Edoardo Puglielli; Rosanna De Amicis; Stefano Necozione; Carlo Masciocchi; Massimo Gallucci
Journal:  Neuroradiology       Date:  2005-07-21       Impact factor: 2.804

7.  Efficacy, safety and patterns of response and recurrence in patients with recurrent high-grade gliomas treated with bevacizumab plus irinotecan.

Authors:  R M Zuniga; R Torcuator; R Jain; J Anderson; T Doyle; S Ellika; L Schultz; T Mikkelsen
Journal:  J Neurooncol       Date:  2008-10-25       Impact factor: 4.130

8.  Diagnostic value of contrast-enhanced fluid-attenuated inversion recovery MR imaging of intracranial metastases.

Authors:  Nil Ercan; Serap Gultekin; Halil Celik; Turgut E Tali; Yusuf A Oner; Gonca Erbas
Journal:  AJNR Am J Neuroradiol       Date:  2004-05       Impact factor: 3.825

9.  Early postoperative MRI overestimates residual tumour after resection of gliomas with no or minimal enhancement.

Authors:  Sinan M K Belhawi; Friso W A Hoefnagels; Johannes C Baaijen; Esther Sanchez Aliaga; Jaap C Reijneveld; Jan J Heimans; Frederik Barkhof; W Peter Vandertop; Philip C De Witt Hamer
Journal:  Eur Radiol       Date:  2011-02-18       Impact factor: 5.315

10.  PET imaging in the surgical management of pediatric brain tumors.

Authors:  Benoit Pirotte; Francesco Acerbi; Alphonse Lubansu; Serge Goldman; Jacques Brotchi; Marc Levivier
Journal:  Childs Nerv Syst       Date:  2007-03-14       Impact factor: 1.532

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.